OpenELIS/Global 2.6 Release Notes

Release Date: May 4, 2012

CONTENTS


1. Application administration

1.1 Identified tests for Malaria surveillance in Haiti

2. Reporting

2.1 Malaria Test Surveillance report

2.2 Malaria Case Surveillance report

3 Interoperability and Standards

3.1 Toward HL7 compliance with CDA

4. Bug fixes

1. Application administration

1.1 Identified tests for Malaria surveillance in Haiti

In Haiti, we have begun developing support for surveillance testing for Malaria. This required working with local stakeholders to determine the specific tests to include in reports and verifying their appropriate representation in the Haiti Clinical test catalog. These tests include:
  • Recherché de plasmodium
  • Malaria test rapide

2. Reporting


We have developed two reports for Malaria surveillance, including Malaria Test Surveillance report and Malaria Case Surveillance report. The user can turn on surveiilane reporting through the “Configuration des Rapports de Résultats” link in the Administration section of OpenELIS (see Figure). Under the “Malaria Surveillance” section, the user can set the URL for the receiving service and the export time for the Malaria test surveillance report. Similarly Under the “Malaria Case Surveillance” section, the user can set the URL for the receiving service. Case reports are sent whenever a new positive Malaria result is entered into OpenELIS. 


2.1 Malaria Test Surveillance report

This report tracks the number of positive Malaria test results entered into OpenELIS over a specified period of time. The report is formatted in xml that can be automatically sent to surveillance authority. The reporting period, included tests, and IP of receiving system can be specified by the user in the administration section of OpenELIS.

In this release, we have developed a Malaria Test Surveillance report for Haiti Clinical. The report is generated daily and includes both the total number of negative results and the number of positive results for Recherché de plasmodium test (i.e., P. Falciparum, P, Vivax, P. Malariae, and P. Ovale) and Malaria rapide test. The Malaria test Surveillance report includes the following data elements:
  • Report date
  • Site number
  • Reporting period
  • "Recherche de plasmodiun - Especes"
    • Number of completed tests: "3"
    • Number of positive results -P. Falciparum
    • Number of ositive results -P. Vivax
    • Number of positive results -P. Malariae
    • Number of positive results -P.Ovale
  • ”Malaria test rapide (sang total and serum)"
    • Number of completed tests
    • Number of positive results

2.2 Malaria Case Surveillance report

This report tracks positive patient cases of Malaria. The report is created in compiance with the clinical document architecture (CDA) prescribed by Health-level 7 (HL7) standards (http://www.hl7.org/). CDA is a document markup standard that specifies the structure and semantics of clinical documents, such as lab results, to support information exchange between information systems. The CDA uses the XD-LAB laboratatory techncial framework, an IHE implementation for sharing lab results (http://ihe.net/Technical_Framework/index.cfm#laboratory). The XD-LAB report contains the following data elements:
  • Demographics:
    • patient ID (a unique identifier for the patient)
    • first & last name
    • address (including street, city, county, state, post code)
    • gender
    • birthdate
    • telephone
  • For every malaria test result for the patient:
    • lab section name
    • lab test name
    • lab test LOINC code
    • lab result date & time
    • lab result type
    • lab result value
    • Lab result notes
  • Miscellaneous
    • laboratory name
    • laboratory ID (a unique code identifying the lab, if available)
    • laboratory address (including street, city, county, state, post code), if available
    • laboratory telephone, if available
    • language identifier (what language was the text sent for all elements above)

3 Interoperability and Standards

3.1 Toward HL7 compliance with CDA

In our development of the new surveillance functionality included in this release, we have made a substantial effort to support standards-based reporting. This effort includes the implementation of surveillance test reports in the universal format of xml, and surveillance case reports in the HL7 standard CDA. This standards-based approach to reporting will help ensure effective and sustainable health information exchange in the long-term.

4. Bug fixes  

We have fixed a number of reported bugs including but not limited to the following:
  • Corrected lab section names on workplan by lab sectionscreen pull down menu, screen, and print reports.
  • Updated lab sections that are listed in the non-conformity report to only those departments that are active.
  • Corrected a problem that was preventing the generation of workplans for Mycologie lab section in Haiti LNSP configuration.
  • Corrected a problem that was preventing user access to non-conformity reporting in Haiti Clinical configuration.
  • Corrected several interface problems in the workplan module that were displaying content in a new window rather than inline in the same window.
  • Corrected an error in the test count reported in the utilization report for Haiti Clinical configuration. Previously, test runs reported excluded reruns. For example, If a test was rerun, it was not counted as an additional run on that day, but if it was rerun on a different day, it was counted. The fix corrected this problem so that all runs, including reruns are counted each day. Thus, if a test is run once and then rerun on the same day, the run count is 2 for that day
Comments